In the announement Lepu said
“We also look forward to exploring possible collaborative opportunities with Viralytics as part of our goal to develop a significant position in the Chinese oncology market,” added Dr. Pu.
Correct me if you don't agree but China is a very addressable market and perhaps the regulatory route for getting to market is a little quicker than in USA!!!
